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1Abstract: This study examined the release of cetyl-
pyridinium chloride and benzalkonium chloride 
from fatty acid chelate temporary dental cement and 
their antimicrobial effects. The cement was Cavex 
Temporary, and either cetylpyridinium chloride or 
benzalkonium chloride was added (1% or 5% by 
mass), incorporating into the base paste. Release 
of the additives was determined by reverse-phase 
high-performance liquid chromatography. Possible 
chemical interactions between the cement compo-
nents and additives were examined by Fourier 
transform infrared (FTIR) spectroscopy. Antimicro-
bial effects were assessed by measuring the zone of 
inhibition around sample discs after 24 h in a Strep-
tococcus mutans culture. FTIR spectroscopy showed 
no interaction with cement components. For both 
additives, release was by diffusion for approximately 
the first 6 hours, with equilibration after about 2 
weeks. Diffusion coefficients were 1.76 m2 s½ to 8.05 
× 10−12 m2 s½ and total release was 10.3 to 44.7% of 
additive loading. Zones of inhibition with additive 
were significantly larger than those for control discs. 
In conclusion, the antimicrobial properties of Cavex 
temporary cement are improved by the addition of 
the antimicrobial compounds cetylpyridium chloride 
and benzalkonium chloride, which are released by a 
diffusion process.
Keywords: temporary cement; cetylpyridinium chloride; 
benzalkonium chloride; FTIR; HPLC; 
diffusion.
Introduction
Several recent studies have reported the incorporation 
of antimicrobial compounds into tooth-colored dental 
restorative materials, namely composite resins (1-5) and 
glass-ionomer cements (6-9). Release of sufficient anti-
microbial compound kills or at least inhibits offending 
microorganisms, thus protecting adjacent hard tissues 
from attack.
A number of substances have been used as antimicro-
bial additives in this way, including chlorhexidine (5) 
and silver (1) (in composite resins), and chlorhexidine 
(6), benxalkonium chloride (10), and cetylpyridinium 
chloride (11) (in the case of glass-ionomers). Even 
without additives, glass-ionomer cements have some 
antimicrobial characteristics that result from release of 
fluoride species (12). However, because fluoride release 
is low, the antimicrobial effect is limited, and glass-
ionomers may not have clinically useful antimicrobial 
activity (13).
The addition of antimicrobial compounds to glass-
ionomers substantially improved their antimicrobial 
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2properties in vitro (6,10). Unfortunately, antimicrobial 
compounds tend to impede the setting reaction, and this 
leads to weaker set cements (6,10) and lower surface 
hardness (7), as compared with specimens without addi-
tives. In addition, release of the antimicrobial compound 
is limited and cease within about 4 weeks. A high propor-
tion of the additive therefore remains inside the cement 
indefinitely (6,10,11).
Materials and Methods
Cavex Temporary Cement (Cavex BV, Haarlem, The 
Netherlands), was used in this study. It is a commercial 
eugenol-free temporary cement based on fatty acids 
chelating with zinc ions obtained from zinc oxide powder. 
The antimicrobial compounds used were cetylpyridinium 
chloride and benzalkonium chloride (both supplied by 
Sigma-Aldrich, Dorset, UK). The cement was mixed 
according to the manufacturer’s instructions at a ratio of 
1 g of ‘base’ paste to 0.5 g of ‘catalyst’ paste, and anti-
microbial compound was incorporated at levels 1% and 
5% by total mass by pre-mixing the necessary quantity of 
additive with the base paste. Manual mixing was done on 
a glass plate with the aid of a metal spatula.
The freshly mixed pastes were transferred to silicone 
rubber molds and placed between glass microscope 
slides to form the specimens (diameter 6 mm; depth 2 
mm). They were allowed to cure fully in the molds at 
37°C for 1 h. Each disc was then removed and placed in 
5 cm3 of deionized water held in polypropylene tubes. 
The samples were stored at 37°C, then at time periods of 
1 h, 2 h, 3 h, 6 h, 24 h, 1 week, and 2 weeks, a volume 
of 0.1 cm3 was removed from the storage solution and 
analyzed by reverse-phase high-performance liquid 
chromatography (HPLC). This analysis was carried out 
in triplicate for each sample-type. 
HPLC analysis of either cetylpyridium chloride 
or benzalkonium chloride was done with an Agilent 
1200 system fitted with a reverse-phase C-18 Kromasil 
column (length 150 × 4.60 mm). A 20 μL injection 
volume was used, and the flow rate was 1.0 cm3/min. The 
mobile phase was an isocratic system consisting of 55:45 
acetonitrile:water with an added drop of glacial acetic 
acid. A variable wavelength detector set to 254 nm was 
used for detection.
Once release had equilibrated, release profiles were 
used to calculate Mt/M∞ values (i.e., the ratio of release 
at time t and at equilibrium). These values were plotted 
against the square root of time, t½ which yielded a 
straight line from which the diffusion coefficient was 
estimated by using the best-fit line was determined with 
least-squares regression. The Student t-test was used to 
evaluate the significance of any differences in release 
data and diffusion coefficients.
Attenuated total reflectance (ATR) Fourier transform 
infrared (FTIR) spectra were obtained for the Cavex 
discs which had been cured for 24 h with and without 
the anti-microbial additives. The spectrometer used was 
a Perkin Elmer Spectrum One with a Universal Diamond 
ATR attachment. The range of data collection was 650 to 
4,000 cm−1, and 10 accumulated scans at a resolution of 
2 cm−1 were obtained.
The antimicrobial activities of Cavex cement alone 
and with varying amounts of antimicrobial additive 
were evaluated with the semi-quantitative Kirby-Bauer 
inhibition zone method. Streptococcus mutans NCIMB 
13700 was used as the test microorganism. Experiments 
involved inoculation of 100 cm3 of Nutrient Broth 
(Oxoid) with 0.1 cm3 of an overnight culture of the 
bacterium. The resulting culture was then incubated for 
24 h, with shaking, at 37°C. For each sample-type, a set 
of three 0.2 cm3 volumes of the resulting culture were 
spread on nutrient agar plates and two cement discs were 
placed on each plate. These plates were then incubated 
at 37°C for 24 h, and examined for clear zones. The final 
population density of the spread plates was 1.5 (± 0.7) 
× 108 colony-forming units per plate. The one-tailed 
Fig. 1   Release profiles for benzalkonium chloride (BAC) Fig. 2   Release profiles for cetylpyridinium chloride (CPC)
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3t-test was used to determine the statistical significance 
of differences between the antimicrobial activities of 
cement specimens with and without antimicrobial addi-
tives (n = 6, P = 0.05).
Results
Samples released antimicrobial compound at all time 
points (Figs. 1, 2), and required about 2 weeks to reach 
equilibrium in all cases. Release profiles were used to 
determine Mt/M∞ values and the resulting diffusion plots 
of Mt/M∞ vs t½ were linear for about the first 6 hours (Fig. 
3). These plots were used to determine diffusion coef-
ficients with the so-called Stefan approximation, ie by 
substitution into the equation:
D = s2πl2/4,
where s is the slope of the diffusion plot and 2l is the 
specimen thickness.
Release data for both additives at both loadings are 
shown in Table 1. In both cases the R2 value was higher 
for release of the 1% loading than for the 5% loading, 
which indicates that the kinetics were closer to true 
diffusion at this loading. However, even at a 5% loading, 
Fig. 4   FTIR spectra of (a) cement, (b) BAC, (c) cement with 1% 
BAC, and (d) cement with 5% BAC
Fig. 5   FTIR spectra of (a) cement, (b) CPC, (c) cement with 1% 
CPC, and (d) cement with 5% CPC
Fig. 3   Diffusion plots for cement with (a) 1% BAC, (b) 5% 
BAC, (c) 1% CPC, and (d) 5% CPC
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4the deviation from true diffusion was only slight. In all 
cases, substantial amounts of additive were retained in 
the cement at equilibrium, and higher loadings resulted 
in greater release of both additives.
FTIR spectra of cement specimens with and without 
additives are shown in Figs. 4 and 5. The bands in these 
spectra were identified, shown in Table 2. The presence 
of the additives did not result in new bands or shifts in 
existing bands. This finding is consistent with the absence 
of any chemical interaction between the additives and the 
cement components. 
The antimicrobial effects of substances released from 
the Cavex cement are shown in Table 3. Cavex itself 
showed a small zone of inhibition, but the zone was much 
larger when either antimicrobial additive was present. 
The zone was significantly larger for 5% than for 1% 
benzalkonium chloride. However, the zone of inhibition 
did not differ significantly between the two loadings of 
cetylpyridinium chloride.
The zone of inhibition was larger when antimicrobial 
additives were present, and t-calc was greater than t-crit 
(P = 0.05). These differences were significant and anti-
microbial release was sufficient to inhibit growth of the 
S. mutans test organism in all cases.
Discussion
Both of the antimicrobial compounds studied were 
released in useful amounts from the fatty acid chelate 
cement Cavex. For about the first 6 h, release was diffu-
sion-based in both substances, as shown by the linear 
dependency on t½. Release equilibrated after approxi-
mately 2 weeks, at which time substantial amounts of 
antimicrobial compound remained in the cement. Similar 
behavior has been observed in other dental materials, 
including composite resins (4,5) and cements (6,8,14). 
A previous study (11) of cetylpyridinium chloride 
release from a chelate cement reported that release was 
similar when the additive was mixed first with the base 
paste or with the catalyst paste. This is consistent with 
the absence of a chemical interaction between cetylpyri-
dinium chloride and the cement components. However, 
the effect of varying the loading of the additive was not 
Table 1  Diffusion and release data for benzalkonium chloride (BAC) and cetylpyridinium chloride (CPC)
Property 1% BAC 5% BAC 1% CPC 5% CPC
Diffusion coefficient (m2s1/2) 6.61 × 10−12 8.05 × 10−12 1.76 × 10−12 2.27 × 10−12
R2 0.985 0.974 0.999 0.985
Maximum release (ppm) 127 147 47 148
% release 44.7 10.3 16.5 10.4
Table 2  FTIR assignments of major bands in components of Cavex temporary cement 
and the antimicrobial additives
Assignment Cavex (cm−1) BAC (cm−1) CPC (cm−1)
C-H bend 703 689




C-N stretch 1050, 1134 1179
C-H bend 1377
C-H bend 1457 1459 1472
C-C stretch 1577 1574
C=C aromatic bend 1620
C=N stretch 1637
COOH stretching 1738
C-H stretching 2851 2853 2849
C-H stretching 2920 2921 2913
OH stretching 3373
Table 3 Inhibition zones for cement with and without additives (1% and 5% loadings)
S. mutans Cement 1% BAC 5% BAC 1% CPC 5% CPC
Zone of inhibition (mm) 0.80 ± 1.1a 2.8 ± 0.80b 4.7 ± 0.58c 2.6 ± 0.55b 2.8 ± 0.84b
Significant differences (P < 0.05) are indicated by different superscript letters.
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5previously studied. We found that both the diffusion coef-
ficient and the total amount released increase when larger 
amounts of substance are incorporated. Nevertheless, 
the zone of inhibition for 5% cetylpyridinium chloride 
was not significantly larger than that for the1% loading. 
However, in both cases release yielded a zone of inhibi-
tion larger than that for the cement itself and there was a 
significant inhibitory effect on the S. mutans culture.
These findings are potentially useful clinically. Incor-
poration of broad-spectrum antimicrobial compounds 
into temporary cement might help maintain a substan-
tially sterile region around a temporary crown or similar 
dental device. This could prove beneficial for patients, as 
it would limit caries development near the restoration. 
However, future studies should examine whether the 
amount released is sufficient to provide useful protection 
in vivo.
Both of the present antimicrobial compounds were 
inert within the chelate cement and, as indicated by FTIR, 
did not interact chemically with any cement component. 
Setting of this cement involves co-ordination of zinc ions 
from the zinc oxide filler with the carboxylic acid groups 
of the fatty acid. The characteristic absorption that shows 
lack of interaction is that due to the carbonyl group (C=O), 
which is present at at 1,738 cm−1 in Cavex, and shows no 
significant shift in the presence of either cetylpyridinium 
chloride or benzalkonium chloride. Other bands in the 
1,500 to 1,650 cm−1 region also do not change, which 
confirms the absence of any chemical reaction. This 
inertness of the additives toward the components of the 
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